Literature DB >> 15808903

Peptide Tyrosine Arginine, a potent immunomodulatory peptide isolated and structurally characterized from the skin secretions of the dusky gopher frog, Rana sevosa.

Ciaren Graham1, Alexandra E Irvine, Stephen McClean, Stephen C Richter, Peter R Flatt, Chris Shaw.   

Abstract

An octadecapeptide was isolated from the skin secretions of the dusky gopher frog (Rana sevosa) on the basis of histamine release from rat peritoneal mast cells. This peptide was purified to homogeneity by HPLC and found to have the following primary structure, YLKGCWTKSYPPKPCFSR, using both Edman degradation chemistry and peptide sequencing using high-resolution mass spectrometry (Q-TOF MS). The peptide, named peptide Tyrosine Arginine (pYR) shares 77.8% homology with peptide Leucine Arginine (pLR). The effects of the natural amidated peptide, non-amidated peptide and C-loop region of pYR on granulopoiesis and neutrophil apoptosis were investigated. All three analogues inhibited the early development of granulocyte macrophage colonies from bone marrow stem cells but did not induce apoptosis of the end stage granulocytes, the mature neutrophil. Thus, pYR is a novel member of an important and emerging new class of amphibian peptides with hemopoietic actions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808903     DOI: 10.1016/j.peptides.2004.12.006

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclization.

Authors:  U Malik; O N Silva; I C M Fensterseifer; L Y Chan; R J Clark; O L Franco; N L Daly; D J Craik
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

2.  Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor.

Authors:  Yuxi Miao; Guanzhu Chen; Xinping Xi; Chengbang Ma; Lei Wang; James F Burrows; Jinao Duan; Mei Zhou; Tianbao Chen
Journal:  Biomolecules       Date:  2019-07-14

Review 3.  Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications.

Authors:  Agata Gitlin-Domagalska; Aleksandra Maciejewska; Dawid Dębowski
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-25

4.  A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea.

Authors:  Luyao Zhang; Xiaoling Chen; Yue Wu; Mei Zhou; Chengbang Ma; Xinping Xi; Tianbao Chen; Brian Walker; Chris Shaw; Lei Wang
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

5.  Identification and Target-Modification of SL-BBI: A Novel Bowman-Birk Type Trypsin Inhibitor from Sylvirana latouchii.

Authors:  Xi Chen; Dong Chen; Linyuan Huang; Xiaoling Chen; Mei Zhou; Xinping Xi; Chengbang Ma; Tianbao Chen; Lei Wang
Journal:  Biomolecules       Date:  2020-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.